Profile data is unavailable for this security.
About the company
Bullfrog AI Holdings, Inc. is a technology-enabled drug development company. The Company is focused specifically on advanced artificial intelligence/machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.
- Revenue in USD (TTM)116.67k
- Net income in USD-6.76m
- Incorporated2020
- Employees9.00
- LocationBullfrog AI Holdings Inc325 Ellington Blvd, Unit 317GAITHERSBURG 20878United StatesUSA
- Phone+1 (240) 658-6710
- Fax+1 (302) 531-3150
- Websitehttps://www.bullfrogai.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bio Green Med Solution Inc | 81.00k | -6.97m | 4.81m | 12.00 | -- | 0.4835 | -- | 59.32 | -80.13 | -80.13 | 0.0775 | 2.03 | 0.012 | -- | 0.0821 | -- | -80.35 | -65.34 | -175.85 | -83.85 | 20.99 | -- | -6,714.82 | -17,774.73 | 5.07 | -241.39 | 0.00 | -- | -89.76 | -- | 50.73 | -- | -- | -- |
| Bioxytran Inc | 0.00 | -2.11m | 4.81m | 2.00 | -- | -- | -- | -- | -0.0235 | -0.0235 | 0.00 | -0.0326 | 0.00 | -- | -- | -- | -1,340.44 | -1,468.56 | -- | -- | -- | -- | -- | -- | -- | -1.99 | -- | -- | -- | -- | 47.08 | -- | -- | -- |
| Cyclerion Therapeutics Inc | 2.86m | -2.20m | 4.91m | 1.00 | -- | 0.4843 | -- | 1.72 | -0.7587 | -0.7587 | 1.00 | 2.58 | 0.2957 | -- | 39.65 | 2,855,000.00 | -22.77 | -53.70 | -24.80 | -63.57 | -- | -- | -77.02 | -1,913.83 | -- | -- | 0.00 | -- | -- | -15.00 | 75.72 | -- | -- | -- |
| Aspire Biopharma Holdings Inc | 1.94k | -28.70m | 4.95m | -- | -- | -- | -- | 2,551.26 | -65.96 | -65.96 | 0.0022 | -9.26 | 0.0004 | -- | -- | -- | -633.21 | -- | -- | -- | 45.36 | -- | -1,479,598.00 | -- | 0.1708 | -6.20 | -- | -- | -- | -- | -380.85 | -- | -- | -- |
| Weed Inc | 0.00 | -755.25k | 4.96m | 2.00 | -- | -- | -- | -- | -0.0058 | -0.0058 | 0.00 | -0.0038 | 0.00 | -- | -- | 0.00 | -133.78 | -117.17 | -- | -371.94 | -- | -- | -- | -- | -- | -22.55 | -- | -- | -- | -- | -1,518.25 | -- | -- | -- |
| Silexion Therapeutics Corp | 0.00 | -9.25m | 4.97m | 11.00 | -- | 0.7125 | -- | -- | -25.21 | -25.21 | 0.00 | 2.23 | 0.00 | -- | -- | 0.00 | -125.80 | -- | -221.96 | -- | -- | -- | -- | -- | -- | -84.50 | 0.1808 | -- | -- | -- | -223.39 | -- | -- | -- |
| Xenetic Biosciences Inc | 2.86m | -3.16m | 4.98m | 2.00 | -- | 0.8478 | -- | 1.74 | -2.05 | -2.05 | 1.85 | 2.57 | 0.436 | -- | -- | 1,429,470.00 | -48.14 | -42.99 | -57.42 | -46.44 | -- | -- | -110.40 | -373.71 | -- | -- | 0.00 | -- | -1.56 | 171.11 | 4.22 | -- | -- | -- |
| Acurx Pharmaceuticals Inc | 0.00 | -9.17m | 5.02m | 4.00 | -- | 0.9751 | -- | -- | -8.54 | -8.54 | 0.00 | 2.02 | 0.00 | -- | -- | 0.00 | -151.72 | -158.12 | -291.07 | -208.61 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 3.26 | -- | -- | -- |
| Processa Pharmaceuticals Inc | 0.00 | -12.93m | 5.03m | 10.00 | -- | 0.8047 | -- | -- | -35.00 | -35.00 | 0.00 | 2.76 | 0.00 | -- | -- | 0.00 | -206.50 | -104.23 | -270.68 | -112.35 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.55 | -- | -- | -- |
| BioNexus Gene Lab Corp | 9.47m | -2.30m | 5.06m | 30.00 | -- | 0.5641 | -- | 0.5345 | -1.28 | -1.28 | 5.27 | 3.79 | 1.02 | 6.73 | 6.42 | -- | -24.68 | -6.00 | -27.80 | -7.75 | 14.77 | 14.31 | -24.27 | -4.98 | 6.81 | -1,354.05 | 0.00 | -- | -2.66 | 137.09 | 39.20 | -- | 77.67 | -- |
| VivoSim Labs Inc | 140.00k | -1.98m | 5.22m | 5.00 | -- | 0.7383 | -- | 37.26 | -0.1898 | -0.1898 | 0.068 | 2.71 | 0.017 | -- | 4.59 | 10,769.23 | -24.12 | -51.63 | -34.26 | -56.47 | 98.57 | -- | -1,416.43 | -2,952.99 | -- | -- | 0.00 | -- | 32.11 | -42.01 | 83.04 | -- | -- | -- |
| Bullfrog AI Holdings Inc | 116.67k | -6.76m | 5.25m | 9.00 | -- | 2.47 | -- | 45.01 | -0.6936 | -0.6936 | 0.0119 | 0.1866 | 0.0319 | -- | -- | 12,963.33 | -184.34 | -- | -233.50 | -- | 18.76 | -- | -5,770.66 | -- | -- | -- | 0.0278 | -- | -100.00 | -- | -31.42 | -- | -- | -- |
| MetaVia Inc | 0.00 | -16.22m | 5.26m | 9.00 | -- | 0.5703 | -- | -- | -13.88 | -13.88 | 0.00 | 2.88 | 0.00 | -- | -- | 0.00 | -87.87 | -99.54 | -167.49 | -140.07 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -121.27 | -- | -48.18 | -- |
| Calidi Biotherapeutics Inc | 0.00 | -25.62m | 5.61m | 28.00 | -- | 0.7812 | -- | -- | -9.62 | -9.62 | 0.00 | 1.00 | 0.00 | -- | -- | 0.00 | -194.84 | -- | -1,279.90 | -- | -- | -- | -- | -- | -- | -58.24 | 0.1544 | -- | -- | -- | 18.49 | -- | -- | -- |
| Alaunos Therapeutics Inc | 6.00k | -4.03m | 5.74m | 1.00 | -- | 2.02 | -- | 955.97 | -2.29 | -2.29 | 0.0034 | 1.27 | 0.0017 | -- | -- | 6,000.00 | -110.67 | -63.80 | -145.65 | -77.93 | -- | -- | -67,083.34 | -7,084.74 | -- | -- | 0.00 | -- | 100.00 | -- | 86.68 | -- | -- | -- |
| CTT Pharmaceutical Holdings Inc | 0.00 | -1.67m | 5.76m | 0.00 | -- | 2.89 | -- | -- | -0.0822 | -0.0822 | 0.00 | 0.0346 | 0.00 | -- | -- | -- | -317.28 | 13.49 | -448.83 | 304.48 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -3,454.52 | -- | -- | -- |
Data as of Feb 17 2026. Currency figures normalised to Bullfrog AI Holdings Inc's reporting currency: US Dollar USD
4.66%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 131.89k | 1.16% |
| DRW Securities LLCas of 31 Dec 2025 | 102.06k | 0.90% |
| Anson Funds Management LPas of 30 Sep 2025 | 80.75k | 0.71% |
| Geode Capital Management LLCas of 31 Dec 2025 | 72.72k | 0.64% |
| Fortem Financial Group LLCas of 31 Dec 2025 | 50.00k | 0.44% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 25.57k | 0.22% |
| G1 Execution Services LLCas of 30 Sep 2025 | 19.43k | 0.17% |
| HRT Financial LPas of 31 Dec 2025 | 18.80k | 0.17% |
| UBS Securities LLCas of 31 Dec 2025 | 15.17k | 0.13% |
| Citadel Securities LLCas of 30 Sep 2025 | 15.03k | 0.13% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
